A 42-year-old man with a 10-year history of poorly controlled type 2 diabetes mellitus presents to the emergency department with a 4-day history of progressive fatigue, nausea, and mild dyspnea. He admits to poor medication adherence and has been on a very low-carbohydrate diet for weight loss. Vital signs: HR 98/min, RR 22/min, BP 128/82 mmHg. Laboratory findings: blood glucose 380 mg/dL, pH 7.22, HCO₃⁻ 14 mEq/L, serum β-hydroxybutyrate 6.8 mmol/L (normal <0.6), serum osmolality 315 mOsm/kg. Which organ is responsible for the majority of ketone body synthesis in this patient, and what is the primary substrate being utilized?

Explanation

## Organ-Specific Ketone Body Synthesis ### The Liver as the Ketone Factory **Key Point:** The **liver is the primary (and almost exclusive) site of ketone body synthesis**, accounting for >90% of whole-body ketogenesis. This is because: 1. **Hepatic mitochondria contain the complete ketogenic enzyme machinery:** - HMG-CoA synthase 2 (HMGCS2) — rate-limiting enzyme, unique to mitochondria - HMG-CoA lyase (HMGCL) - 3-ketoacyl-CoA transferase (thiophorase) 2. **Liver lacks 3-ketoacyl-CoA transferase in the cytosol** → cannot utilize ketones it produces 3. **High capacity for β-oxidation** → generates abundant acetyl-CoA ### The Primary Substrate: Free Fatty Acids **High-Yield:** In DKA and starvation, **free fatty acids (FFAs) from adipose tissue lipolysis** are the dominant substrate for ketogenesis, not glucose or amino acids. | Condition | Primary FFA Source | Glucagon:Insulin Ratio | Ketone Output | |-----------|-------------------|------------------------|---------------| | Fed state | Minimal | Low | Negligible | | Fasting (12–24 h) | Adipose HSL activation | Moderate ↑ | Moderate ↑ | | Prolonged starvation | Maximal adipose lipolysis | High ↑↑ | High ↑↑ | | DKA | Uncontrolled lipolysis | Very high ↑↑↑ | Severe ↑↑↑ | ### Biochemical Pathway in This Patient ```mermaid flowchart TD A["Adipose Tissue<br/>(HSL activated by ↑ glucagon)"]:::action --> B["Free Fatty Acids<br/>(FFAs released)"]:::outcome B --> C["Hepatic Mitochondria<br/>(β-oxidation)"]:::action C --> D["Acetyl-CoA<br/>(excess, TCA cycle saturated)"]:::outcome D --> E["HMG-CoA Synthase 2<br/>(rate-limiting)"]:::action E --> F["Acetoacetate"]:::outcome F --> G["β-Hydroxybutyrate<br/>(major ketone in blood)"]:::outcome G --> H["Peripheral Tissues<br/>(muscle, brain, kidney)"]:::action H --> I["Acetyl-CoA for TCA Cycle"]:::outcome ``` ### Why FFAs, Not Glucose or Amino Acids? **Clinical Pearl:** In this patient: - **Glucose is already elevated** (380 mg/dL) → not a limiting substrate - **Insulin is deficient** → cannot suppress lipolysis; FFAs flood the liver - **Amino acids are secondary** → proteolysis occurs only in prolonged starvation; in DKA, lipolysis dominates - **Glycerol cannot be oxidized to acetyl-CoA** → it enters gluconeogenesis, not ketogenesis ### The Ketone Bodies Produced 1. **Acetoacetate** (unstable, minor in blood) 2. **β-Hydroxybutyrate** (major form, 70–80% of total ketones; his level is 6.8 mmol/L, severely elevated) 3. **Acetone** (volatile, exhaled → fruity breath) **Mnemonic: "FAT makes Ketones"** — **F**ree **A**tty **A**cids → **T**he liver → **K**etones. ### Why This Patient's Ketone Level Is So High - Poor glycemic control (glucose 380 mg/dL) → persistent hyperglucagonemia - Low-carbohydrate diet → further reduces insulin signaling and increases lipolysis - Poor medication adherence → no exogenous insulin to suppress HSL - Result: **uncontrolled FFA mobilization → hepatic ketogenesis overwhelms peripheral utilization** [cite:Lehninger Principles of Biochemistry Ch 23; Harrison 21e Ch 297]